FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaidi, A. K.
Right arrow Articles by Ali, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaidi, A. K.
Right arrow Articles by Ali, H.
Related Collections
Right arrowRelated Articles
(The FASEB Journal. 2006;20:199.)
© 2006 FASEB

Response to C3a, mast cells, and asthma

Asifa K. Zaidi*, Yassine Amrani{dagger}, Reynold A. Panettieri{dagger} and Hydar Ali*,1

* Department of Pathology, School of Dental Medicine;
{dagger} Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

1 Correspondence: E-mail: ali{at}path.dental.upenn.edu

This is in response to a "Letter to the Editor (1) " by Dr. Bradding regarding our manuscript entitled "Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact" that was published in your journal recently (2) . Dr. Bradding contends that our manuscript, which utilizes a C3a-responsive human mast cell line, is misleading because "it ignores wealth of consistent literature demonstrating that human lung mast cells and human lung fragments do not exhibit any response to C3a or C5a." We disagree with this view for the reasons discussed below.

Although studies performed in the 1980s and 1990s, showed that dispersed human lung mast cells are unresponsive to C3a and C5a (3 4 5) , these studies did not characterize the expression of C3a receptor in mast cells and failed to consider the possibility that lung tissue may contain a subpopulation of mast cells that could be responsive to anaphylatoxins. Human mast cells (MC) consist of a mixture of at least two cell types that can be distinguished based on the protease content of their granules. It is well documented that MCTC cells (tryptase- and chymase-positive) that are found predominantly in the skin are responsive to C3a and C5a whereas MCT cells (tryptase positive) present in other tissues are unresponsive to these anaphylatoxins (6) . The previous demonstration that dispersed lung mast cells did not respond to C3a or C5a probably reflects the fact that ~90% of these cells are MCT cells (7) . Indeed, a recent report by Oskeritzian et al. (8) showed that MCTC cells purified from a mixture of human lung mast cells are highly responsive to C5a for histamine release and leukotriene C4 generation, mediators that promote airway hyperreactivity. Most importantly, mast cells that infiltrate into the airway smooth muscle in asthma are positive for both tryptase and chymase (9) . Given that MCTC cells are also responsive to C3a for mediator release (10 , 11) , we argue that a C3a responsive human mast cell line is an appropriate in vitro cellular model to delineate the signaling pathways involved in mast cell-airway smooth cell interaction relevant to asthma.

FOOTNOTES

The opinions expressed in editorials, essays, letters to the editor, and other articles comprising the Up Front section are those of the authors and do not necessarily reflect the opinions of FASEB or its constituent societies. The FASEB Journal welcomes all points of view and many voices. We look forward to hearing these in the form of op-ed pieces and/or letters from its readers addressed to journals@faseb.org.

REFERENCES

  1. Bradding, P. (2005) C3a, mast cells, and asthma. FASEB J. 19,1585[Free Full Text]
  2. Thangam, E. B., Venkatesha, R. T., Zaidi, A. K., Jordan-Sciutto, K. L., Goncharov, D. A., Krymskaya, V. P., Amrani, Y., Panettieri, R. A., Jr, Ali, H. (2005) Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. FASEB J. 19,798-800[Abstract/Free Full Text]
  3. Fureder, W., Agis, H., Semper, H., Keil, F., Maier, U., Muller, M. R., Czerwenka, K., Hofler, H., Lechner, K., Valent, P. (1995) Differential response of human basophils and mast cells to recombinant chemokines. Ann. Hematol. 70,251-258[Medline]
  4. Tainsh, K. R., Liu, W. L., Lau, H. Y., Cohen, J., Pearce, F. L. (1992) Mast cell heterogeneity in man: unique functional properties of skin mast cells in response to a range of polycationic stimuli. Immunopharmacology 24,171-180[CrossRef][Medline]
  5. Schulman, E. S., Post, T. J., Henson, P. M., Giclas, P. C. (1988) Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J. Clin. Invest. 81,918-923[Medline]
  6. Fureder, W., Agis, H., Willheim, M., Bankl, H. C., Maier, U., Kishi, K., Muller, M. R., Czerwenka, K., Radaszkiewicz, T., Butterfield, J. H., et al (1995) Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155,3152-3160[Abstract]
  7. Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., Schwartz, L. B. (1986) Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83,4464-4468[Abstract/Free Full Text]
  8. Oskeritzian, C. A., Zhao, W., Min, H. K., Xia, H. Z., Pozez, A., Kiev, J., Schwartz, L. B. (2005) Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J. Allergy Clin. Immunol. 115,1162-1168[CrossRef][Medline]
  9. Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., Pavord, I. D. (2002) –1705. N. Engl. J. Med. 346,1699[Abstract/Free Full Text]
  10. Venkatesha, R. T., Thangam, E. B., Zaidi, A. K., Ali, H. (2005) Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol. Immunol. 42,581-587[CrossRef][Medline]
  11. el-Lati, S. G., Dahinden, C. A., Church, M. K. (1994) Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102,803-806[CrossRef][Medline]

Related Articles

C3a, mast cells, and asthma
Peter Bradding
FASEB J 2005 19: 1585. [Full Text] [PDF]

Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact
E. Berla Thangam, Rampura T. Venkatesha, Asifa K. Zaidi, Kelly L. Jordan-Sciutto, Dmitry A. Goncharov, Vera P. Krymskaya, Yassine Amrani, Reynold A. Panettieri, Jr., and Hydar Ali
FASEB J 2005 0: 04-2797fjev1-1111. [Abstract] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaidi, A. K.
Right arrow Articles by Ali, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaidi, A. K.
Right arrow Articles by Ali, H.
Related Collections
Right arrowRelated Articles


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS